Vanda Pharmaceuticals Inc.

VNDA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$70,022$80,983$111,796$102,316
Short-Term Investments$223,730$244,567$229,112$272,327
Receivables$50,541$44,993$44,603$47,101
Inventory$2,042$2,169$1,923$1,726
Other Curr. Assets$21,161$22,209$20,476$15,420
Total Curr. Assets$367,496$394,921$407,910$438,890
Property Plant & Equip (Net)$11,899$12,468$12,475$12,677
Goodwill$0$0$0$0
Intangibles$108,841$110,593$112,344$114,096
Long-Term Investments$0$0$0$0
Tax Assets$103,073$97,143$89,147$81,440
Other NC Assets$9,831$9,621$10,060$9,101
Total NC Assets$233,644$229,825$224,026$217,314
Other Assets$0$0$0$0
Total Assets$601,140$624,746$631,936$656,204
Liabilities
Payables$0$2,181$5,990$3,498
Short-Term Debt$0$4,678$4,394$4,270
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$117,870$114,630$93,539$92,213
Total Curr. Liab.$117,870$121,489$103,923$99,981
LT Debt$6,227$6,960$7,351$8,090
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$11,044$9,968$9,245$9,587
Total NC Liab.$17,271$16,928$16,596$17,677
Other Liabilities$0$0$0$0
Cap. Leases$0$11,638$11,745$12,360
Total Liabilities$135,141$138,417$120,519$117,658
Equity
Pref Stock$0$0$0$0
Common Stock$59$59$59$58
Retained Earnings-$253,579-$230,993-$203,786-$174,292
AOCI$540$396$383$74
Other Equity$718,979$716,867$714,761$712,706
Total Equity$465,999$486,329$511,417$538,546
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$601,140$624,746$631,936$656,204
Net Debt-$63,795-$69,345-$100,051-$89,956